Trinity Biotech PLC vs VolitionRx Limited
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Trinity Biotech PLC is the larger company by market value: $8 M against $7 M for VolitionRx Limited, 1.1 times as much (market caps of Aug 1, 2026 for Trinity Biotech PLC and Oct 30, 2026 for VolitionRx Limited). Trinity Biotech PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Trinity Biotech PLC had more revenue: $62 M in the year to December 2024 against $2 M for VolitionRx Limited in the year to December 2025.
- Both made a net loss: $32 M for Trinity Biotech PLC and $23 M for VolitionRx Limited.
- Trinity Biotech PLC keeps more of each dollar of sales: a net margin of -51.6% against -1350.3% for VolitionRx Limited.
- VolitionRx Limited's revenue grew faster in its latest fiscal year: +40.6% against +8.3% for Trinity Biotech PLC.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Trinity Biotech PLC TRIB · #26,221 in the world | VolitionRx Limited VNRX · #26,406 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇪 Ireland | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | — | 1998 |
| Size | ||
| Market cap | $8 M | $7 M |
| Revenue | $62 M | $2 M |
| Net income | $-32 M | $-23 M▲ best |
| Valuation | ||
| Price to sales | 0.1× | 2.1× |
| Free cash flow yield | -57.4% | — |
| Profitability | ||
| Gross margin | 34.8% | — |
| Operating margin | -34.4% | — |
| Net margin | -51.6% | — |
| Growth | ||
| Revenue growth | 8.3% | 40.6%▲ best |
| Revenue growth, 3 years a year | -8.8% | 77.4%▲ best |
| Cash | ||
| Free cash flow margin | -7.5% | — |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026; ratios FY2024 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Trinity Biotech PLC or VolitionRx Limited?
Trinity Biotech PLC is the larger company by market value: $8 M against $7 M for VolitionRx Limited, 1.1 times as much (market caps of Aug 1, 2026 for Trinity Biotech PLC and Oct 30, 2026 for VolitionRx Limited). Trinity Biotech PLC's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Trinity Biotech PLC or VolitionRx Limited?
Trinity Biotech PLC had more revenue: $62 M in the year to December 2024 against $2 M for VolitionRx Limited in the year to December 2025. Both made a net loss: $32 M for Trinity Biotech PLC and $23 M for VolitionRx Limited.
Which is more profitable, Trinity Biotech PLC or VolitionRx Limited?
Trinity Biotech PLC keeps more of each dollar of sales: a net margin of -51.6% against -1350.3% for VolitionRx Limited.
Which is growing faster, Trinity Biotech PLC or VolitionRx Limited?
VolitionRx Limited's revenue grew faster in its latest fiscal year: +40.6% against +8.3% for Trinity Biotech PLC.
More about Trinity Biotech PLC
More about VolitionRx Limited
Sources#
Every figure on this page comes from these, with the date shown next to it.